Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Merck suffers a setback in Europe over its new Keytruda formulation

In a setback for Merck, a Dutch court ordered a halt to the manufacturing and marketing of a subcutaneous formulation of Keytruda in several European countries.

STAT+: Merck suffers a setback in Europe over its new Keytruda formulation

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Wednesday 7 October →